In the pharmaceutical world, the application of a definition developed for one purpose to other areas frequently has unintended consequences, resulting in confusion and unnecessary compliance burdens. The term "impurity" is one such example and was a subject of lengthy debate at IPEC-Americas Dec. 8 Excipient Composition Committee.
